Viimeisin päivitys :
19/11/2024
Vitamiinit   Ascorbic acid  
Injektioneste
Stabilius liuoksessa Stabilius seoksissa Tekijät, jotka vaikuttavat stabiliuteen Yhteensopivuus Antotapa Viitteet pdf
   Kemiallinen rakenne  

Kauppanimi   Kauppanimi     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acido ascorbico Chile, Ecuador, Kolumbia, Venezuela
Acmel Turkki
Adeene vitamina C Argentiina
Amsac Meksiko
Ascorbic acid Australia, Iso-Britannia, New Zealand, Yhdistyneet arabiemiirikunnat
Ascorbil Marokko
Ascorbinezuur Hollanti
Ascorell Saksa
Ascorvit Saksa
Bio C Marokko
C Viton Egypti
Cebion Saksa
Cemin Ecuador
Cevalin Meksiko
Cevarol Egypti
Cevitol Itävalta
Infalet Meksiko
Laperox Meksiko
Laroscorbine Marokko, Ranska
Mega C acid Kanada
Mel C Itävalta
Osve vitamin C Iran
Pascorbin Ecuador
Synum Saksa
Viciforte Italia
Vitamedic Romania
Vitamin C Iran, Itävalta, Kanada, Saksa, Unkari
Vitamina C Argentiina, Italia, Kolumbia, Romania, Venezuela
Vitamine C Sveitsi
Vitaminum C Puola
Viitteet   Injektioneste   Viitteet : Ascorbic acid  
tyyppi julkaisu
319 Lehti Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
552 Lehti Martinez JF, Trissel LA, Gilbert DL.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Int J Pharm Compound 1997 ; 1: 356-358.
939 Lehti Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1057 Lehti Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1995 Lehti Chin A, Liu S, Ting-Chan J, Gill MA.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
3128 Laboratorio Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3549 Laboratorio Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3588 Laboratorio Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
Sandoz 2011
3646 Laboratorio Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3674 Laboratorio Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3932 Laboratorio Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4154 Laboratorio Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4245 ilmoitus Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
2019
4471 Laboratorio Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4510 Lehti Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.
Stability studies of parenteral nutrition with a high dose of vitamin C.
J Oncol Pharm Practice 2020 ;26,8:1894–1902

  Mentions Légales